Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 USD | -3.50% | -13.29% | -27.13% |
05-15 | HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating | MT |
05-14 | IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.13% | 94.21M | |
+33.04% | 49.46B | |
+1.99% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+12.00% | 26.61B | |
-22.67% | 18.64B | |
+8.37% | 13.16B | |
+30.32% | 12.55B | |
+24.00% | 12.1B |
- Stock Market
- Equities
- IOBT Stock
- News IO Biotech, Inc.
- HC Wainwright Initiates IO Biotech With Buy Rating, Sets $10 Price Target